Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hong

Showing results (201-210 of 273) with videos related to

Pageof 28
Sort By:
Scientific Reports|May 24, 2022
Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiencesShuyang Yao, Funda Meric-Bernstam, David Hong, et al.
JCO Precision Oncology|October 16, 2018
Clinical Use of Precision Oncology Decision SupportAmber Johnson, Yekaterina B Khotskaya, Lauren Brusco, et al.
Oncotarget|November 7, 2014
Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumabGerald S Falchook, Jennifer J Wheler, Aung Naing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsFunda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.
ACS Medicinal Chemistry Letters|September 16, 2021
Development of Pyrazolopyrimidine Anti-<i>Wolbachia</i> Agents for the Treatment of FilariasisPaul McGillan, Neil G Berry, Gemma L Nixon, et al.
JCO Precision Oncology|December 27, 2021
Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non-Small-Cell Lung Cancer Harboring <i>MET</i> Exon 14 SkippingXiuning Le, Lingzhi Hong, Chuck Hensel, et al.
Cancer Medicine|November 25, 2016
Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experienceZhijie Wang, Naiyi Shi, Aung Naing, et al.
JACC. Advances|June 28, 2024
Long-Term Cost-Effectiveness of Fractional Flow Reserve-Based Percutaneous Coronary Intervention in Stable and Unstable AnginaDavid Hong, Hyunsoo Kim, Hankil Lee, et al.
Infection and Drug Resistance|December 1, 2018
The biological evaluation of fusidic acid and its hydrogenation derivative as antimicrobial and anti-inflammatory agentsPan-Pan Wu, Hao He, W David Hong, et al.
Journal of the American Heart Association|March 9, 2023
Discriminative Role of Invasive Left Heart Catheterization in Patients Suspected of Heart Failure With Preserved Ejection FractionKi Hong Choi, Jeong Hoon Yang, Jeong Hun Seo, et al.
Pageof 28

Showing results (201-210 of 273) with videos related to

Sort By:
Pageof 28
Scientific Reports|May 24, 2022
Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiencesShuyang Yao, Funda Meric-Bernstam, David Hong, et al.
JCO Precision Oncology|October 16, 2018
Clinical Use of Precision Oncology Decision SupportAmber Johnson, Yekaterina B Khotskaya, Lauren Brusco, et al.
Oncotarget|November 7, 2014
Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumabGerald S Falchook, Jennifer J Wheler, Aung Naing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsFunda Meric-Bernstam, Lauren Brusco, Kenna Shaw, et al.
ACS Medicinal Chemistry Letters|September 16, 2021
Development of Pyrazolopyrimidine Anti-<i>Wolbachia</i> Agents for the Treatment of FilariasisPaul McGillan, Neil G Berry, Gemma L Nixon, et al.
JCO Precision Oncology|December 27, 2021
Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non-Small-Cell Lung Cancer Harboring <i>MET</i> Exon 14 SkippingXiuning Le, Lingzhi Hong, Chuck Hensel, et al.
Cancer Medicine|November 25, 2016
Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experienceZhijie Wang, Naiyi Shi, Aung Naing, et al.
JACC. Advances|June 28, 2024
Long-Term Cost-Effectiveness of Fractional Flow Reserve-Based Percutaneous Coronary Intervention in Stable and Unstable AnginaDavid Hong, Hyunsoo Kim, Hankil Lee, et al.
Infection and Drug Resistance|December 1, 2018
The biological evaluation of fusidic acid and its hydrogenation derivative as antimicrobial and anti-inflammatory agentsPan-Pan Wu, Hao He, W David Hong, et al.
Journal of the American Heart Association|March 9, 2023
Discriminative Role of Invasive Left Heart Catheterization in Patients Suspected of Heart Failure With Preserved Ejection FractionKi Hong Choi, Jeong Hoon Yang, Jeong Hun Seo, et al.
Pageof 28